ArticleJAAD reviews2024
Biopsychosocial impact of keloids on quality of life.
Article in JAAD reviews, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Add-on benefits of botulinum toxin type A in combination or sequential therapies for scar management: a systematic review and meta-analysis.Frontiers in pain research (Lausanne, Switzerland) · 2026Pooled it
- Systemic Comorbidities of Keloid and Hypertrophic Scars: A Phenome-Wide Association Study in a Multiethnic U.S. Pediatric Cohort.American journal of clinical dermatology · 2026Article
- Anxiety and depression in patients with single versus multiple keloids: A cross-sectional study.JAAD international · 2026Article
- Understanding and Comparing Current Practice for Ear Keloid Scars: A Narrative Systematic Review.Journal of plastic and reconstructive surgery · 2026Review
- Clinical and Therapeutic Predictors of Keloid Recurrence: Outcomes in a European Cohort of 206 Patients.Journal of clinical medicine · 2026Article
- Identification and histological validation of autophagy-related core genes ADRB2 and PLK2 in keloids, with integrated immune infiltration analysis.Frontiers in immunology · 2026Article
- Managing common dermatologic needs in transgender and gender-diverse adolescents.Current pediatrics reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Keloids are a prevalent, although understudied, dermatologic condition commonly affecting people of color. In the clinical setting, keloids negatively impact many aspects of patient quality of life (QoL), but this area has not been comprehensively characterized. This review identifies and summarizes studies in which the QoL impact of keloids has been measured utilizing validated survey and questionnaire instruments, including the SCAR-Q and Dermatology Life Quality Index. Study findings are grouped into physical and emotional factors that together comprise 7 biopsychosocial domains: pain and itch, mobility, visibility, gender and age, psychosocial, stigma, and cosmetic. These domains interact in a complex network that negatively impacts QoL of patients with keloid. Enhanced understanding of the significance of these domains will pave the way for the performance of large, rigorous epidemiologic studies that will lead to the development of efficacious keloid therapies that improve not only physical but also psychosocial functioning, enabling clinicians to provide holistic care that enhances patient QoL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.